Nevro Total Current Assets 2013-2024 | NVRO
Nevro total current assets from 2013 to 2024. Total current assets can be defined as the sum of all assets that are classified as current because they will provide a benefit within one year.
| Nevro Annual Total Current Assets (Millions of US $) |
|
|---|---|
| 2023 | $531 |
| 2022 | $563 |
| 2021 | $531 |
| 2020 | $753 |
| 2019 | $422 |
| 2018 | $444 |
| 2017 | $441 |
| 2016 | $420 |
| 2015 | $283 |
| 2014 | $201 |
| 2013 | $75 |
| 2012 | $49 |
| Nevro Quarterly Total Current Assets (Millions of US $) |
|
|---|---|
| 2024-06-30 | $486 |
| 2024-03-31 | $493 |
| 2023-12-31 | $531 |
| 2023-09-30 | $522 |
| 2023-06-30 | $531 |
| 2023-03-31 | $535 |
| 2022-12-31 | $563 |
| 2022-09-30 | $566 |
| 2022-06-30 | $483 |
| 2022-03-31 | $490 |
| 2021-12-31 | $531 |
| 2021-09-30 | $539 |
| 2021-06-30 | $557 |
| 2021-03-31 | $739 |
| 2020-12-31 | $753 |
| 2020-09-30 | $742 |
| 2020-06-30 | $717 |
| 2020-03-31 | $414 |
| 2019-12-31 | $422 |
| 2019-09-30 | $401 |
| 2019-06-30 | $401 |
| 2019-03-31 | $410 |
| 2018-12-31 | $444 |
| 2018-09-30 | $433 |
| 2018-06-30 | $432 |
| 2018-03-31 | $428 |
| 2017-12-31 | $441 |
| 2017-09-30 | $427 |
| 2017-06-30 | $410 |
| 2017-03-31 | $407 |
| 2016-12-31 | $420 |
| 2016-09-30 | $409 |
| 2016-06-30 | $402 |
| 2016-03-31 | $266 |
| 2015-12-31 | $283 |
| 2015-09-30 | $279 |
| 2015-06-30 | $292 |
| 2015-03-31 | $188 |
| 2014-12-31 | $201 |
| 2014-09-30 | $53 |
| 2014-06-30 | |
| 2014-03-31 | |
| 2013-12-31 | |
| 2013-09-30 | |
| 2012-12-31 | $49 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.217B | $0.425B |
| Nevro Corp. is a medical device company which engages in developing and commercializing a neuromodulation platform for the treatment of chronic pain, primarily in the leg. The company is known for developing and commercializing the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. Additionally, the company's HF10 therapy provides long-lasting relief from chronic back and leg pain. Nevro's flagship Senza SCS system has been consistently driving the top line. Since its commercial launch in the United States, the system raked in significant revenues. These apart, Senza is commercially available in Europe since 2010 and in Australia since 2011. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $233.063B | 27.94 |
| Intuitive Surgical (ISRG) | United States | $171.313B | 97.00 |
| Alcon (ALC) | Switzerland | $47.672B | 33.56 |
| IQVIA Holdings (IQV) | United States | $44.239B | 25.07 |
| IDEXX Laboratories (IDXX) | United States | $42.083B | 50.62 |
| Edwards Lifesciences (EW) | United States | $40.680B | 26.07 |
| DexCom (DXCM) | United States | $27.834B | 39.69 |
| STERIS (STE) | Ireland | $23.508B | 27.43 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.781B | 0.00 |
| Waters (WAT) | United States | $19.789B | 29.50 |
| Hologic (HOLX) | United States | $18.981B | 20.64 |
| Sysmex ADR (SSMXY) | Japan | $12.317B | 38.62 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.224B | 13.70 |
| Teleflex (TFX) | United States | $11.380B | 17.69 |
| Globus Medical (GMED) | United States | $9.423B | 26.36 |
| Penumbra (PEN) | United States | $7.597B | 78.86 |
| Glaukos (GKOS) | United States | $6.721B | 0.00 |
| Masimo (MASI) | United States | $6.081B | 32.57 |
| TransMedics (TMDX) | United States | $5.203B | 222.80 |
| PROCEPT BioRobotics (PRCT) | United States | $4.309B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.304B | 25.17 |
| Tandem Diabetes Care (TNDM) | United States | $2.791B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.773B | 16.26 |
| Veracyte (VCYT) | United States | $2.593B | 160.76 |
| Inari Medical (NARI) | United States | $2.586B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.562B | 20.88 |
| Nihon Kohden (NHNKY) | Japan | $2.508B | 15.61 |
| RxSight (RXST) | United States | $2.003B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.360B | 6.19 |
| Pulse Biosciences (PLSE) | United States | $1.163B | 0.00 |
| OPKO Health (OPK) | United States | $1.130B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.112B | 19.84 |
| Artivion (AORT) | United States | $1.046B | 96.04 |
| Alphatec Holdings (ATEC) | United States | $0.864B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.728B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.682B | 17.23 |
| SiBone (SIBN) | United States | $0.654B | 0.00 |
| AxoGen (AXGN) | United States | $0.638B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.616B | 0.00 |
| IRadimed (IRMD) | United States | $0.614B | 33.19 |
| Paragon 28 (FNA) | United States | $0.581B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.526B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.341B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.330B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.327B | 9.98 |
| ClearPoint Neuro (CLPT) | United States | $0.322B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.306B | 0.00 |
| Inogen (INGN) | United States | $0.253B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.251B | 0.00 |
| NeuroPace (NPCE) | United States | $0.199B | 0.00 |
| Accuray (ARAY) | United States | $0.190B | 0.00 |
| CVRx (CVRX) | United States | $0.189B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.179B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.173B | 12.15 |
| Alpha Tau Medical (DRTS) | Israel | $0.162B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.135B | 0.00 |
| 908 Devices (MASS) | United States | $0.128B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.122B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.114B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.103B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.099B | 14.81 |
| Hyperfine (HYPR) | United States | $0.070B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.068B | 0.00 |
| InspireMD (NSPR) | Israel | $0.066B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.063B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.062B | 0.00 |
| Envoy Medical (COCH) | United States | $0.061B | 0.00 |
| LENSAR (LNSR) | United States | $0.049B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.045B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.038B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.036B | 0.00 |
| Precision Optics (POCI) | United States | $0.035B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.035B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.034B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.032B | 0.00 |
| Neuronetics (STIM) | United States | $0.029B | 0.00 |
| Lifeward (LFWD) | United States | $0.028B | 0.00 |
| DarioHealth (DRIO) | United States | $0.027B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.022B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.022B | 0.00 |
| Spectral AI (MDAI) | United States | $0.021B | 0.00 |
| PAVmed (PAVM) | United States | $0.017B | 0.00 |
| NexGel (NXGL) | United States | $0.016B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.016B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.015B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.013B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.013B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.010B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.005B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.003B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |